Thema: NL0012661870
IFRX, NL0012661870
entrepreneur-1340649_1920.jpg - Foto: THN
InflaRx stock trades at 1.49 euros as weekend trading pauses
InflaRx is scheduled to report results on November 3. Investors are watching the next update on the biotech's clinical pipeline.
ad-hoc-news.de, heute 12:44 Uhr
IFRX, NL0012661870
InflaRx presented kidney data. InflaRx stock stood at a ...
Izicopan cut kidney injury markers in two hamster models on October 22, 2026. InflaRx stock costs EUR 1.55 on October 29, 2026.
ad-hoc-news.de, 29.10.26 13:07 Uhr
IFRX, NL0012661870
InflaRx schedules November 3 results and values InflaRx ...
Izicopan cut kidney injury markers in two models on October 22, 2026. InflaRx stock costs EUR 1.41 on October 27, 2026, with a USD 232.1 million market value.
ad-hoc-news.de, 27.10.26 12:59 Uhr
IFRX, NL0012661870
InflaRx presents kidney data for InflaRx stock investors ...
Izicopan showed kidney potential in two hamster models on October 22, 2026. A 100 mg/kg dose and 14-day regimen frame InflaRx stock research.
ad-hoc-news.de, 25.10.26 12:59 Uhr
IFRX, NL0012661870
InflaRx presents kidney data while InflaRx stock costs EUR ...
InflaRx presents izicopan data at Kidney Week on October 22, 2026. InflaRx stock costs EUR 1.37 at Lang & Schwarz.
ad-hoc-news.de, 22.10.26 13:56 Uhr
IFRX, NL0012661870
InflaRx appoints Alperovich. Needham targets InflaRx stock ...
InflaRx named Alperovich on October 1, 2026, after 20 years in drug development. InflaRx stock costs EUR 1.34 on October 20, 2026, with Needham at USD 8.00.
ad-hoc-news.de, 20.10.26 13:12 Uhr
IFRX, NL0012661870
InflaRx presents kidney data. Needham sets USD 8.00 target ...
InflaRx will present izicopan data on October 22, 2026. InflaRx stock has a USD 8.00 Needham target and 90.00 percent blockade.
ad-hoc-news.de, 18.10.26 13:29 Uhr
IFRX, NL0012661870
InflaRx schedules kidney data: Needham targets InflaRx stock ...
InflaRx presents izicopan data on October 22, 2026, after 90.00 percent blockade. InflaRx stock costs EUR 1.33 on October 15, 2026 in trading.
ad-hoc-news.de, 15.10.26 13:01 Uhr
IFRX, NL0012661870
InflaRx presents kidney data: Needham upgrades InflaRx stock ...
Izicopan achieved at least 90.00 percent C5a blockade over 14 days. InflaRx stock has a poster scheduled for October 22, 2026 in Denver.
ad-hoc-news.de, 13.10.26 03:39 Uhr
IFRX, NL0012661870
InflaRx presents kidney data and Needham raises InflaRx ...
